Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RapidBio Systems is a private biotechnology and diagnostics company developing a portable rapid pathogen-detection system for food safety testing. Its handheld platform is designed to detect food-borne bacterial pathogens such as Salmonella, Escherichia coli O157:H7 and non-O157 strains, Listeria, and Campylobacter with results in approximately 10 minutes. The company says its technology was licensed from the University of Arizona and is intended for point-of-testing use in fields, warehouses, food processing settings, and distribution environments. RapidBio Systems appears to be focused on commercialization of a device-and-consumables model rather than drug development, with manufacturing intended to be outsourced to partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RapidBio Systems.